Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gitta Boons"'
Autor:
Gitta Boons, Timon Vandamme, Marc Peeters, Matthias Beyens, Ann Driessen, Katrien Janssens, Karen Zwaenepoel, Geert Roeyen, Guy Van Camp, Ken Op de Beeck
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: Detection of tumor-specific alterations in cell-free DNA (cfDNA) has proven valuable as a liquid biopsy for several types of cancer. So far, use of cfDNA remains unexplored for pancreatic neuroendocrine tumor (PNET) patients.Methods: From
Externí odkaz:
https://doaj.org/article/e4f2b6373ae4431680b67adeb33baa75
Autor:
Ken Op de Beeck, Marc Peeters, Guy Van Camp, Isabel Dero, Wim Demey, Marc Simoens, Bart Op de Beeck, Katrien Janssens, Konstantinos Papadimitriou, Tim Rondou, Geert Roeyen, Willem Lybaert, Laura Mariën, Timon Vandamme, Gitta Boons
Purpose:As noninvasive biomarkers are an important unmet need for neuroendocrine neoplasms (NEN), biomarker potential of genome-wide molecular profiling of plasma cell-free DNA (cfDNA) was prospectively studied in patients with NEN.Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6c27bb7251e8af1b147ffe5b84327d
https://doi.org/10.1158/1078-0432.c.6531069
https://doi.org/10.1158/1078-0432.c.6531069
Autor:
Ken Op de Beeck, Marc Peeters, Guy Van Camp, Isabel Dero, Wim Demey, Marc Simoens, Bart Op de Beeck, Katrien Janssens, Konstantinos Papadimitriou, Tim Rondou, Geert Roeyen, Willem Lybaert, Laura Mariën, Timon Vandamme, Gitta Boons
Supplementary Data from Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92459175465411f0b977fec91f5b3ae7
https://doi.org/10.1158/1078-0432.22483095.v1
https://doi.org/10.1158/1078-0432.22483095.v1
Autor:
Konstantinos Papadimitriou, Willem Lybaert, Timon Vandamme, Marc Peeters, Marc Simoens, Katrien Janssens, Ken Op de Beeck, Laura Mariën, Isabel Dero, Bart Op de Beeck, Gitta Boons, Tim Rondou, Wim Demey, Geert Roeyen, Guy Van Camp
Publikováno v:
Clinical cancer research
Purpose: As noninvasive biomarkers are an important unmet need for neuroendocrine neoplasms (NEN), biomarker potential of genome-wide molecular profiling of plasma cell-free DNA (cfDNA) was prospectively studied in patients with NEN. Experimental Des
Autor:
G. Van Camp, K. Op de Beeck, K Biermann, W. W. de Herder, Timon Vandamme, Marc Peeters, Kimberly Kamp, Matthias Beyens, Gitta Boons, Leo J. Hofland, Patrick Pauwels, Anne Schepers
Publikováno v:
Endocrine-related cancer
Endocrine-Related Cancer, 26(1), 1-12. Bioscientifica Ltd
Endocrine-Related Cancer, 26(1), 1-12. Bioscientifica Ltd
Mutations in DAXX/ATRX, MEN1 and genes involved in the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway have been implicated in pancreatic neuroendocrine neoplasms (pNENs). However, mainly mutations present in the m
Autor:
Dieter Peeters, Ann Driessen, Cristin G. Print, Joe Ibrahim, Geert Roeyen, Ben Lawrence, Marian Peeters, Ken Op de Beeck, Gitta Boons, Guy Van Camp, Timon Vandamme
Publikováno v:
Cancers, 12(6):1461, 1-20. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 12, Iss 1461, p 1461 (2020)
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1461, p 1461 (2020)
Cancers
Volume 12
Issue 6
DNA methylation is a crucial epigenetic mechanism for gene expression regulation and cell differentiation. Furthermore, it was found to play a major role in multiple pathological processes, including cancer. In pancreatic neuroendocrine neoplasms (PN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51617a9020672f4b6572fdfea9e41c53
https://pure.eur.nl/en/publications/63a3129a-c50c-45c4-ae63-914f6f1684a6
https://pure.eur.nl/en/publications/63a3129a-c50c-45c4-ae63-914f6f1684a6
Publikováno v:
Reviews in Endocrine & Metabolic Disorders, 20(3), 333-351. Springer Netherlands
Reviews in endocrine and metabolic disorders
Reviews in endocrine and metabolic disorders
High-throughput analysis, including next-generation sequencing and microarrays, have strongly improved our understanding of cancer biology. However, genomic data on rare cancer types, such as neuroendocrine neoplasms, has been lagging behind. Neuroen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faaaf6464885c0ca940710bf56044b3d
https://pure.eur.nl/en/publications/3c1eba39-0e23-4d31-bd87-bcdaec2c8381
https://pure.eur.nl/en/publications/3c1eba39-0e23-4d31-bd87-bcdaec2c8381
Autor:
Geert Roeyen, Timon Vandamme, Gitta Boons, Marc Peeters, Katrien Janssens, Guy Van Camp, Wim Demey, Isabel Dero, Konstantinos Papadimitriou, Tim Rondou, Willem Lybaert, Ken Op de Beeck
Publikováno v:
Journal of Clinical Oncology. 39:372-372
372 Background: Recent studies, including our proof-of-concept study, demonstrated the possibility to detect tumor-derived molecular alterations in cell-free DNA (cfDNA) from plasma of patients with a gastroenteropancreatic neuroendocrine neoplasm (G
Autor:
Timon Vandamme, G. Van Camp, Karen Zwaenepoel, K. Janssens, Geert Roeyen, K. Op de Beeck, Gitta Boons, Matthias Beyens, Marc Peeters
Publikováno v:
Annals of Oncology. 29:viii477